Active ingredient
Salbutamol + ipratropium bromide

Pharmaceutical form

Solution for nebulisation or oral use

Dosage

15 ml – 1 vial

Indications

Treatment of bronchial asthma and obstructive pulmonary disease with asthma overlap; whenever it is necessary to associate an anticholinergic drug to a beta-adrenergic drug.